持续静脉泵入乌拉地尔与持续静脉泵入硝普钠治疗高血压合并急性左心力衰竭的疗效比较

张云; 张蜿莉; 李正盛; 王心群; 杨世平

doi:10.13898/j.cnki.issn.1000-2200.2017.08.014

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

持续静脉泵入乌拉地尔与持续静脉泵入硝普钠治疗高血压合并急性左心力衰竭的疗效比较

张云 , 张蜿莉 , 李正盛 , 王心群 , 杨世平

文章导航 > 蚌埠医学院学报 > 2017, 42 > 8: (1058-1060)

引用本文:

Citation:

持续静脉泵入乌拉地尔与持续静脉泵入硝普钠治疗高血压合并急性左心力衰竭的疗效比较

四川石油管理局总医院急诊科, 四川成都 610231

作者简介: 张云(1970-),男,主治医师.

中图分类号: R541.61

Clinical effect comparision of continuous pumping ebrantil with nitroprusside in the treatment of hypertension complicated with acute left heart failure

Department of Emergency, Petroleum Management Bureau General Hospital, Chengdu Sichuan 610231, China
CLC number: R541.61

摘要: 目的：探讨持续静脉泵入乌拉地尔与持续静脉泵入硝普钠治疗高血压合并急性左心力衰竭（心衰）的疗效。方法：选取高血压合并急性左心衰病人112例，按随机数字法分为观察组和对照组，每组56例，2组均在综合治疗基础上，对照组给予持续静脉泵入硝普钠，观察组给予持续静脉泵入乌拉地尔，观察2组的临床疗效和不良反应。结果：治疗24h后观察组治疗总有效率为92.9%，高于对照组的71.4%（P<0.05）。治疗1h后2组心率、收缩压和舒张压均较治疗前改善，治疗后观察组收缩压变化的差值较对照组改善（P<0.05），但2组心率、舒张压变化差异均无统计学意义（P>0.05）。治疗前2组N-端脑利钠肽水平差异无统计学意义（P>0.05），治疗后2组N-端脑利钠肽水平均较治疗前有所下降，但观察组下降更为明显（P<0.05）。对照组不良反应发生率高于观察组（P<0.05）。结论：与硝普钠相比，经静脉泵入乌拉地尔在治疗高血压并发急性左心衰临床疗效好且不良反应少，值得临床推广应用。
- 心力衰竭 /
- 高血压 /
- 乌拉地尔 /
- 硝普钠
Abstract: Objective:To compare the clinical effects of continuous pumping ebrantil with nitroprusside in the treatment of hypertension complicated with acute left heart failure.Methods:One hundred and twelve patients with acute left heart failure complicated with hypertension were divided into the observation group and control group according to the random number method(56 cases each group).The observation group and control group were treated with ebrantil and nitroprusside by continuous intravenous pumping based on comprehensive treatment,respectively.The clinical effects and adverse reactions in two groups were observed.Results:After 24 h of treatment,the total effective rate in observation group(92.9%) was significantly higher than that in control group(71.4%)(P<0.05).After 1 h of treatment,the heart rate,systolic blood pressure and diastolic blood pressure in two groups were significantly improved(P<0.05),the difference of systolic blood pressure in observation group was significantly improved compared with control group(P<0.05),and the differences of changes of the heart rate and diastolic blood pressure between two groups were not statistically significant(P>0.05).The difference of the level of NT-proBNP between two groups before treatment was not statistically significant(P>0.05).The levels of NT-proBNP in two groups after treatment decreased compared with before treatment,but the decreasing degree of which was more obvious in observation group(P<0.05).The incidence rate of adverse reactions in observation group was lower than that in control group(P<0.05).Conclusions:Compared with nitroprusside,the treatment of hypertension complicated with acute left heart failure with ebrantil has lower adverse reactions and good effects,which is worthy of clinical promotion.
- heart failure /
- hypertension /
- ebrantil /
- nitroprusside

[1]	李立新,方宁远.持续静脉泵入乌拉地尔与泵入硝普钠治疗高血压急症的效果比较[J].西部医学,2015,13(3):356.
[2]	盛红成,方兴.乌拉地尔与硝普钠治疗高血压并发急性左心衰竭的临床疗效比较[J].浙江实用医学,2015,21(3):164.
[3]	刘峰.持续静脉泵入两种药物治疗高血压合并急性左心力衰竭的疗效比较[J].检验医学与临床,2015,16(15):2232.
[4]	史振军,张红.乌拉地尔治疗充血性心力衰竭合并肾功能不全的疗效观察[J].实用心脑肺血管病杂志,2010,18(3):351.
[5]	尚跃丰,王文欣,邓娜,等.乌拉地尔治疗急性心力衰竭的Meta分析[J].中国城乡企业卫生,2010,25(3):11.
[6]	李繁云,李繁丽.持续静脉泵入单硝酸异山梨酯或硝普钠抢救急性左心衰竭64例[J].中国煤炭工业医学杂志,2010,14(4):583.
[7]	董卫华,黄泰康,邹雅敏,等.硝普钠治疗高血压急症有效性和安全性的系统评价[J].中国药房,2012,23(40):3778.
[8]	郭华,苏文理.乌拉地尔治疗高血压急症的疗效和安全性研究[J].心血管康复医学杂志,2011,22(6):583.
[9]	曹正.乌拉地尔和硝普钠治疗高血压急症的疗效对比观察[J/CD].中国医学前沿杂志(电子版),2014,7(10):101.
[10]	杨伟,何婧瑜,王艳玲,等.乌拉地尔与硝酸甘油注射液在老年高血压合并糖尿病病人发作急性心力衰竭的临床有效性与安全性[J].首都医科大学学报,2015,36(1):67.
[11]	何婧瑜,华琦.乌拉地尔在心血管疾病中的临床应用[J].首都医科大学学报,2013,34(1):100.
[12]	王智,汪道峰,娄宁.舌下含服硝苯地平和静脉注射乌拉地尔治疗急性术后高血压的疗效观察[J].南方医科大学学报,2011,31(2):317.
[13]	周鹏霞.乌拉地尔与硝普钠治疗高血压脑出血的疗效对比[J].白求恩军医学院学报,2011,9(6):423.

[1]	李莹 , 李社会 . 硝普钠治疗重症手足口病合并高血压患儿疗效观察. 蚌埠医学院学报, 2015, 40(5): 599-601. doi: 10.13898/j.cnki.issn.1000-2200.2015.05.012
[2]	于敏 , 郑志刚 , 田峰 . 乌拉地尔治疗急性左心衰竭的疗效观察. 蚌埠医学院学报, 2012, 36(8): 927-929.
[3]	祖磊 . 芪苈强心胶囊辅助治疗高血压心力衰竭的疗效观察. 蚌埠医学院学报, 2016, 41(9): 1228-1229. doi: 10.13898/j.cnki.issn.1000-2200.2016.09.035
[4]	赵德生 , 佘强 . 脑钠肽和氨基末端脑钠肽前体在心力衰竭中的应用. 蚌埠医学院学报, 2008, 33(1): 121-123.
[5]	黄涛 , 程仁力 . 坎地沙坦对冠心病心力衰竭患者心室重塑及心功能的影响. 蚌埠医学院学报, 2010, 35(9): 914-916.
[6]	郭鹏 , 尹莉 . 美托洛尔治疗急性心肌梗死并发心力衰竭的疗效观察. 蚌埠医学院学报, 2012, 36(8): 966-967.
[7]	程储记 , 方长太 . 无创机械通气联合硝普钠治疗急性心源性肺水肿. 蚌埠医学院学报, 2009, 34(4): 330-332.
[8]	王环宇 , 张福宸 , 张立敏 , 李婷婷 , 张明亮 . 重组人脑利钠肽联合参附注射液治疗急性心肌梗死伴急性心力衰竭的疗效评价. 蚌埠医学院学报, 2018, 43(1): 59-64. doi: 10.13898/j.cnki.issn.1000-2200.2018.01.018
[9]	韦锋 . 重组人脑利钠肽对STEMI并发心力衰竭不同靶血管病变行急诊PCI术后的治疗效果分析. 蚌埠医学院学报, 2020, 45(2): 232-234. doi: 10.13898/j.cnki.issn.1000-2200.2020.02.026
[10]	谢瑞玉 , 李松 . 心力衰竭患者内皮素1和脑钠肽的改变及相关性研究. 蚌埠医学院学报, 2015, 39(7): 949-951. doi: 10.13898/j.cnki.issn.1000-2200.2015.07.041
[11]	杨爱龙 , 周露露 , 陈曦 , 高宏伟 . 中段心房利钠肽原对呼吸困难人群心力衰竭的诊断价值. 蚌埠医学院学报, 2017, 42(12): 1627-1629,1633. doi: 10.13898/j.cnki.issn.1000-2200.2017.12.017
[12]	刘春艳 , 朱昊平 , 余跃天 . 早期重组人脑利钠肽联合无创正压通气治疗急性失代偿性心力衰竭疗效观察. 蚌埠医学院学报, 2014, 38(1): 43-46.
[13]	胡延毅 , 龙红英 , 王鲸竹 . 不同剂量坎地沙坦治疗糖尿病肾病合并高血压效果评价. 蚌埠医学院学报, 2015, 40(1): 62-64. doi: 10.13898/j.cnki.issn.1000-2200.2015.01.020
[14]	杜秀兰 , 吴泽海 . 替米沙坦、福辛普利对原发性高血压患者24h血压及心率的影响. 蚌埠医学院学报, 2008, 33(4): 460-461.
[15]	徐贵霞 , 谢虹 , 单新莉 . 早期慢性肾衰竭合并高血压的临床观察与护理. 蚌埠医学院学报, 2006, 31(3): 309-310.
[16]	张爱雄 . 多巴胺持续泵入治疗顽固性心力衰竭的疗效观察. 蚌埠医学院学报, 2013, 37(9): 1146-1147.
[17]	张学强 . 危重症患者心力衰竭的危险因素分析. 蚌埠医学院学报, 2017, 42(2): 212-214. doi: 10.13898/j.cnki.issn.1000-2200.2017.02.024
[18]	蔡长霞 , 甘桂芬 , 牛毅 , 赵海燕 . 老年心力衰竭合并肺部感染病人病原学分析及预后. 蚌埠医学院学报, 2019, 44(3): 363-365. doi: 10.13898/j.cnki.issn.1000-2200.2019.03.024
[19]	张克良 , 孟令民 , 刘大成 , 贾凤玖 , 徐媛 , 徐淑丽 . 多巴胺、多巴酚丁胺、门冬氨酸钾镁、呋塞米合用治疗顽固性心力衰竭临床观察. 蚌埠医学院学报, 2014, 39(10): 1383-1385.
[20]	王浩 , 李霞 , 林良毅 , 王萍 , 林少华 . 降钙素原对左心室射血分数正常心力衰竭患者病情预后判断价值. 蚌埠医学院学报, 2015, 40(3): 348-350. doi: 10.13898/j.cnki.issn.1000-2200.2015.03.017

点击查看大图

计量

文章访问数: 4002
HTML全文浏览量: 575
PDF下载量: 62
被引次数: 0

持续静脉泵入乌拉地尔与持续静脉泵入硝普钠治疗高血压合并急性左心力衰竭的疗效比较

作者简介: 张云(1970-),男,主治医师.

四川石油管理局总医院急诊科, 四川成都 610231

收稿日期: 2015-11-30

关键词:

摘要: 目的：探讨持续静脉泵入乌拉地尔与持续静脉泵入硝普钠治疗高血压合并急性左心力衰竭（心衰）的疗效。方法：选取高血压合并急性左心衰病人112例，按随机数字法分为观察组和对照组，每组56例，2组均在综合治疗基础上，对照组给予持续静脉泵入硝普钠，观察组给予持续静脉泵入乌拉地尔，观察2组的临床疗效和不良反应。结果：治疗24h后观察组治疗总有效率为92.9%，高于对照组的71.4%（P<0.05）。治疗1h后2组心率、收缩压和舒张压均较治疗前改善，治疗后观察组收缩压变化的差值较对照组改善（P<0.05），但2组心率、舒张压变化差异均无统计学意义（P>0.05）。治疗前2组N-端脑利钠肽水平差异无统计学意义（P>0.05），治疗后2组N-端脑利钠肽水平均较治疗前有所下降，但观察组下降更为明显（P<0.05）。对照组不良反应发生率高于观察组（P<0.05）。结论：与硝普钠相比，经静脉泵入乌拉地尔在治疗高血压并发急性左心衰临床疗效好且不良反应少，值得临床推广应用。

English Abstract

Clinical effect comparision of continuous pumping ebrantil with nitroprusside in the treatment of hypertension complicated with acute left heart failure

Department of Emergency, Petroleum Management Bureau General Hospital, Chengdu Sichuan 610231, China

Received Date: 2015-11-30

Abstract: Objective:To compare the clinical effects of continuous pumping ebrantil with nitroprusside in the treatment of hypertension complicated with acute left heart failure.Methods:One hundred and twelve patients with acute left heart failure complicated with hypertension were divided into the observation group and control group according to the random number method(56 cases each group).The observation group and control group were treated with ebrantil and nitroprusside by continuous intravenous pumping based on comprehensive treatment,respectively.The clinical effects and adverse reactions in two groups were observed.Results:After 24 h of treatment,the total effective rate in observation group(92.9%) was significantly higher than that in control group(71.4%)(P<0.05).After 1 h of treatment,the heart rate,systolic blood pressure and diastolic blood pressure in two groups were significantly improved(P<0.05),the difference of systolic blood pressure in observation group was significantly improved compared with control group(P<0.05),and the differences of changes of the heart rate and diastolic blood pressure between two groups were not statistically significant(P>0.05).The difference of the level of NT-proBNP between two groups before treatment was not statistically significant(P>0.05).The levels of NT-proBNP in two groups after treatment decreased compared with before treatment,but the decreasing degree of which was more obvious in observation group(P<0.05).The incidence rate of adverse reactions in observation group was lower than that in control group(P<0.05).Conclusions:Compared with nitroprusside,the treatment of hypertension complicated with acute left heart failure with ebrantil has lower adverse reactions and good effects,which is worthy of clinical promotion.